Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




SHARP: Ezetimibe/Simvastatin Combo Cuts Atherosclerotic and Vascular Events in Kidney-Disease Patien
Link ID 31077
Title SHARP: Ezetimibe/Simvastatin Combo Cuts Atherosclerotic and Vascular Events in Kidney-Disease Patien
Url http://www.medscape.com/viewarticle/732951?src=rss
Description At a mean of 4.9 years, risk for atherosclerotic events was reduced by 17% among patients taking the combo drug vs placebo. Risk for vascular events was also significantly reduced, by 15.3%. Heartwire
Category Articles > Cardiology
Keywords
Date Nov 23, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Cardiopulmonary Exercise Testing Characteristics in Heart Failure Patients With and Without Concomit
  A dual-diagnosis of HF and COPD may greatly impact cardiopulmonary exercise testing results and more. American Heart Journal
Category:   Articles > Cardiology


2. Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoin
  Can this study settle the controversy over whether preoperative use of ACE inhibitors is safe for patients undergoing CABG? Journal of the American College of Cardiology
Category:   Articles > Cardiology


3. Mechanical-Valve Pioneer, Philanthropist Donald Shiley Dead at 90
  The coinventor of the Bjork-Shiley tilting-disk heart valve gave millions to medical research and other causes. Heartwire
Category:   Articles > Cardiology


4. AHA 2008: Rock On: Keep iPod Headphones Away From Pacemakers/ICDs of Avoid Interference
  Investigators say that as long as patients keep their headphones on their ears and out of their breast pockets, there is no chance of causing damage to their devices that could have clinical repercussions. Heartwire
Category:   Articles > Cardiology


5. New PLATO Data: No Need for Gene Testing in PCI Patients
  New data from genetic substudies of PLATO and TRITON-TIMI 38 show that the efficacy of the new antiplatelet agents ticagrelor and prasugrel do not seem to be affected by loss-of-function genetic variants that contribute in some instances to worse outcomes in those on clopidogrel. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS